Ideaya Biosciences receives ODD for Darovasertib for treating uveal melanoma
Under the ODD, Ideaya may be entitled to certain tax credits, exemption from user fees, and seven years of statutory marketing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ideaya Biosciences
Ideaya and Pfizer expand clinical trial collaboration and supply agreements
The step is taken to evaluate Darovasertib and Crizotinib combination in Metastatic Uveal Melanoma and additional cMET-driven…